• Sonia Ayub Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University Karach 74600, Pakistan
  • Bilqees Fatima
  • Syed Baqir
  • Shyum Naqvi
  • Dilnawaz Sheikh
  • Syed Muzaffar Ali
  • Sheikh Abdul Khaliq


Objective: Present investigation was undertaken to evaluate the susceptibility and resistance pattern of clinical isolates causing different types of infections and to compare the efficacy of antibiotics namely amoxicillin and tetracycline.

Methods: The in-vitro antibacterial activity and resistance patterns of these two well known antibiotics were studied and compared by using the disk diffusion method. For this, one hundred and thirty four clinical isolates comprising of, Staphylococcus aureus (103) and Proteus mirabilis (31) and information were taken regarding patient age, sex and bacterial organism isolation were collected from different local pathological laboratories and hospitals according to the zones (east Karachi, west Karachi, south Karachi and north Karachi) of Karachi (Pakistan) during the time period of February 2015 to June 2015.

Results: Out of the sample analyzed, resistant pattern of one hundred and thirty four (134) clinical isolates of Staphylococcus aureus (103) and Proteus mirabilis (31) were studied by using amoxicillin and tetracycline and the results are among 103 samples of Staphylococcus aureus 4(3.9%) sample showed sensitivity, no clinical isolates showed intermediate response and 99 (96.1%) sample exhibited resistance against amoxicillin while, 84 (81.6%) sample of Staphylococcus aureus were sensitive against tetracycline, 6(5.8%) showed intermediate response and 13(12.6%) were resistant to the tetracycline 30 µg while, 2 (6.5%) clinical isolates showed sensitivity towards Proteus mirabilis, 19(61.31%) showed resistance and 10 (32.3%) showed intermediate resistance against amoxicillin. On the other hand, tetracycline showed 3(9.7 %) resistance against Proteus mirabilis, 26(83.9%) showed sensitivity and 2 (6.5%) clinical isolates showed intermediate resistance.

Conclusion: overall results of the present study showed that the antibacterial activity of tetracycline is more as compare to amoxicillin. Amoxicillin is not the first choice to treat the infections against Proteus mirabilis and Staphylococcus aureus because they showed resistance 96.1% and 61.3% against Proteus mirabilis as compare to tetracycline is the first choice to treat infection which is caused by Staphylococcus aureus and Proteus mirabilis because they showed 81.6% sensitivity against Staphylococcus aureus and 83.9% sensitive against tetracycline.

Keywords: Staphylococcus aureus, Proteus mirabilis, Amoxicillin, Tetracycline.


1. Phimister EG, Arias CA, Murray BE. A new antibiotic and the evolution of resistance. N Engl J Med 2015;372:1168-70.
2. Chopra I, M Roberts. "Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance." Microbiol Mol Biol Rev 2001;65:232-60.
3. Saeed R, Raza G, Muhammad Iqbal Nasiri, Syed Baqir Shyum Naqvi, Aamir Ali Zaidi. Report-Comparative study on resistant pattern of clinical isolates against levofloxacin and cefepime. Pak J Pharm Sci 2013;26:415-9.
4. Arsalan A, Naqvi SBS, Ali SA, Ahmed S, Shakeel O. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi. Pak J Pharm Sci 2015;28:841-7.
5. Theuretzbacher U. Global antibacterial resistance: the never-ending story. J Global Antimicrobial Resistance 2013;1:63-9.
6. Hardman JG, Limbrid LE, Molinoff PB, Ruddon RW, Alferd Goodman, Gilman Goodman. Gilman’s: the pharmacological basis of therapeutics. 10th ed. International ed. Mcgraw-Hill; 1996. p. 1239.
7. Suda T, Hata T, Kawai S, Okamura H, Nishida T. Treatment of tetracycline antibiotics by laccase in the presence of 1-hydroxybenzotriazole. Bioresour Technol 2012;103:498-501.
8. Cunha B. Clinical uses of the tetracyclines. In: The Tetracyclines Springer Berlin Heidelberg; 1985. p. 393-404.
9. Sapadin AN, R Fleischmajer. "Tetracyclines: nonantibiotic properties and their clinical implications." J Am Acad Dermatol 2006;54:258-65.
10. Pal N, Sharma N, Sharma R, Hooja S, Maheshwari RK. Prevalence of multidrug (MDR) and extensively drug resistant (XDR) proteus species in a tertiary care hospital, India. Int J Curr Microbiol Appl Sci 2014;3:243-52.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document M100-S21 (ISBN 1-56238-742-1). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania19087 USA; 2011.
593 Views | 421 Downloads
How to Cite
Ayub, S., B. Fatima, S. Baqir, S. Naqvi, D. Sheikh, S. M. Ali, and S. A. Khaliq. “AMOXICILLIN AND TETRACYCLINE ACTIVITY AGAINST STAPHYLOCOCCUS AUREUS AND PROTEUS MIRABILIS”. International Journal of Current Pharmaceutical Research, Vol. 7, no. 4, 1, pp. 49-52,
Original Article(s)